| LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 |
901 NEW YORK AVENUE, NW, #510
| Address2 |
|
| City |
WASHINGTON
| State |
DC
| Zip Code |
20001
| Country |
USA
|
3. Principal place of business (if different than line 2)
| City |
Irving
| State |
TX
| Zip Code |
75039
| Country |
USA
|
| 5. Senate ID# 40021-00012
|
||||||||
| 6. House ID# 313240000
|
||||||||
| TYPE OF REPORT | 8. Year |
2011
| Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
| 11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income from the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
| Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature |
Digitally Signed By: Michael J. Regier, Senior Vice President of Legal and Corporate Affairs and Chief Counsel
| Date |
10/13/2011
|
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Budget Control Act (S. 365) - Monitored the negotiations to raise the statutory debt ceiling. Opposed deficit reduction proposals that would have made cuts to hospital reimbursements. Raised opposition to possible cuts to Medicare and Medicaid payments to hospitals. Opposed specific cuts to hospital Medicare and Medicaid reimbursement through reductions to indirect medical education and Medicare bad debt payments.
Joint Select Committee on Deficit Reduction - Monitored recommendations being made to the Joint Select Committee for impact on hospital reimbursement and patient access to care. Raised opposition to similar cuts to Medicare and Medicaid hospital reimbursement discussed during debt ceiling debate.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Select Committee on Deficit Reduction - monitored the selection and the activity of the Joint Select Committee under the Budget Control Act.
Hospital Group Purchasing - Education and outreach efforts on the value of group purchasing for hospitals. Advocated in support of proposals to provide greater transparency in the pricing of medical devices.
Unique Device Identification - Advocated for the release regulations creating a unique device identification system for medical devices as required under the Food and Drug Administration Amendments Act of 2007.
Independent Payment Advisory Board (S. 668, H.R. 452) - Supported legislation that would repeal the Independent Payment Advisory Board.
Partnership for Patients - engaged in supporting the national patient safety initiative through the Partnership for Patients.
Drug Shortage (S. 296, H.R. 2245) - Supported legislative efforts aimed at preventing ongoing issues with the shortage of prescription drugs. Monitored efforts from the Food and Drug Administration to address the problem.
340 B (of the Public Health Services Act) Drug Pricing Program - Monitored proposals to extend the drug discount program to inpatient hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Not-for-profit hospital community benefit - Tracked IRS proposals to implement new requirements for tax-exempt hospitals under the Affordable Care Act. Opposed prescriptive requirements that would greatly expand reporting obligations on the Form 990 Schedule H. Monitored proposed guidance from the IRS regarding community health needs assessment requirements for tax-exempt hospitals.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
|
Edward
|
Goodman
|
|
| |
|
Cidette
|
Perrin
|
|
| |
|
Steven
|
Rixen
|
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
| State |
| Zip Code |
| Country |
|
21. Client new principal place of business (if different than line 20)
| City |
| State |
| Zip Code |
| Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
| 3 |
|
||||||
| 2 |
| 4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
|
||||||||||||||
|
|
|
|||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address | Principal place of business (city and state or country) | Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
|
||||||||||||||
|
|
| % | ||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |